U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353398) titled 'Early Study of ART002g1 Injection in HeFH: Safety, Tolerability and Preliminary Efficacy' o... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07350447) titled 'Predictors of Laparoscopy Conversion in Adhesive Small Bowel Obstruction' on Dec. 23, 2025.... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352930) titled 'A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-cons... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352969) titled 'A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients' on Jan. 13. Bri... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353463) titled 'Shanghai Clinical Cohort - Parkinson's Disease (Reserve)' on Nov. 13, 2025. Brief Summary:... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07351266) titled 'Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patien... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352917) titled 'Methotrexate for Severe Vulvar Lichen Sclerosus' on Dec. 19, 2025. Brief Summary: Vulvar l... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07350759) titled 'Observational Study Designed to Detect Decompensation of Congestive Heart Failure (dCHF) Us... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07350889) titled 'Effects of a Specific Dietary Program on Overweight/Obese Women With Polycystic Ovary Syndr... Read More
U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353268) titled 'Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unrese... Read More